🇺🇸 FDA
Pipeline program

γ-globin reactivated autologous hematopoietic stem cells

2021-BRL-103

Unknown mab on_hold

Quick answer

γ-globin reactivated autologous hematopoietic stem cells for Thalassemia Major is a Unknown program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Thalassemia Major
Phase
Unknown
Modality
mab
Status
on_hold

Clinical trials